Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × tislelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 8 Advanced Solid Tumor 6 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Rectal Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Advanced Solid Tumour 2 Adenocarcinoma Of Esophagus 2 mCRPC 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solid Tumor 1 Simpson-Golabi-Behmel syndrome 1 Pseudomyxoma Peritonei 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasm, Residual 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Metastatic Solid Tumors 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1

Interventions

Gemcitabine 8 Mitomycin 5 erdafitinib 4 dodecyl maltoside 4 Cystoscopy 3 Docetaxel 2 BCG Vaccine 2 pirarubicin 1 hydroxycamptothecinum 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1 Epirubicin 1 Drainage 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Accelerometry 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡